ImmunityBio Inc. Common Stock vs Patterson-UTI Energy Inc. Common Stock — how do they compare? ImmunityBio Inc. Common Stock trades at $10.01 (market cap $10.33B), while Patterson-UTI Energy Inc. Common Stock trades at $11.45 (market cap $4.28B). The key difference: ImmunityBio Inc. Common Stock is far larger — about 2.4× Patterson-UTI Energy Inc. Common Stock's market cap, and Patterson-UTI Energy Inc. Common Stock pays a 3.56% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Patterson-UTI Energy Inc. Common Stock for 0 Days on average.
| IBRX | PTEN | |
|---|---|---|
Market Cap | $10.33B | $4.28B |
Volume | 11,745,198 | 5,046,340 |
Sector | Health | Energy |
52-Week High | $11.55 | $13.15 |
52-Week Low | $1.98 | $5.37 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.79B | $5.37B |
Dividend Yield | — | 3.56% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →Patterson-UTI Energy provides drilling, completion, and other oilfield services for oil and gas producers in the United States.
Read more on PTEN →